Published Date: 17 Mar 2023
The American College of Rheumatology (ACR) and the American College of Hip Surgery (AAHKS) have released new guidelines.
Read Full NewsA lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.
An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Prostate Cancer Treatment Associated With Long-Term Complications
3.
Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.
4.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
5.
Snus Linked to Gingival Damage, Raising Safety Questions
1.
Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts
2.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
3.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
4.
Strategic Applications in Hematology in Clinical Decision-Making
5.
Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation